Dynavax Technologies Corp. is a California-based biotechnology company that develops vaccines and immunotherapies. Its lobbying filings show the company spent about $500,000 across four reports (most recent on 2026-01-17) to influence federal policy related to its business interests, such as vaccine regulation, funding, and related health policy. The company handled lobbying in-house.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
This client has not yet disclosed issue activity in the available filings.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
No lobbyists are disclosed for this client yet.
The latest disclosures for this client.
DYNAVAX TECHNOLOGIES CORP.
2TYDYNAVAX TECHNOLOGIES CORP.
Q1YDYNAVAX TECHNOLOGIES CORP.
The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.
DYNAVAX TECHNOLOGIES CORP.
Q3YDYNAVAX TECHNOLOGIES CORP.
Q2YDYNAVAX TECHNOLOGIES CORP.
Q1Y